United States · Who invested in ImmunoMolecular Therapeutics?
ImmunoMolecular Therapeutics's investors include Morningside Ventures, T1D Fund and Colorado University Healthcare Innovation Fund. Morningside Ventures led its latest round.
United States · Series A startup
Who invested in ImmunoMolecular Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $10MOct 2019
- Led by
- Morningside Ventures and T1D Fund
- Investors
- 3 (2 led)
The rounds
- Oct 2019Series A$10M
- Morningside VenturesLead
T1D FundLead- Colorado University Healthcare Innovation Fund
Reported by FinSMEsSEC filing: $3.0M sold, first sale Jun 2019
Everyone who backed them
Morningside VenturesVC firm1round, led 1
Colorado University Healthcare Innovation Fundno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmunoMolecular Therapeutics
How much has ImmunoMolecular Therapeutics raised?
ImmunoMolecular Therapeutics has raised $10M across 1 round since 2019.
When did ImmunoMolecular Therapeutics last raise?
ImmunoMolecular Therapeutics's most recent round was a Series A of $10M in Oct 2019, led by Morningside Ventures.
What was ImmunoMolecular Therapeutics's biggest round?
Its most recent round, $10M in Oct 2019, is also its largest on record.
Who backed ImmunoMolecular Therapeutics first?
ImmunoMolecular Therapeutics's first round on record, in Oct 2019, was backed by Morningside Ventures, T1D Fund and Colorado University Healthcare Innovation Fund.
What stage is ImmunoMolecular Therapeutics at?
ImmunoMolecular Therapeutics's latest named round is a Series A, in Oct 2019.
Where is ImmunoMolecular Therapeutics based?
ImmunoMolecular Therapeutics is based in the United States.
Who led ImmunoMolecular Therapeutics's rounds?
Morningside Ventures led the Series A in 2019.
Companies like ImmunoMolecular Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.